Pharmacokinetics and safety of JNJ-73763989, an RNA interference therapy for hepatitis B virus, in moderately hepatically impaired participants

被引：0
|
作者：
Kakuda, Thomas [1 ]
Halabi, Atef [2 ]
Guinard-Azadian, Carine [3 ]
Nedoschinsky, Katja [3 ]
Nangosyah, Julius [3 ]
Ediage, Emmanuel Njumbe [3 ]
Verboven, Peter [3 ]
Biermer, Michael [3 ]
机构：
[1] Janssen BioPharma Inc, San Francisco, CA USA
[2] Clin Res Serv Kiel GmbH, Kiel, Germany
[3] Janssen Pharmaceut NV, Beerse, Belgium
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PO-1416
引用
收藏
页码：S745 / S745
页数：1
相关论文
共 30 条
  • [1] Pharmacokinetics, Safety, and Tolerability of the siRNA JNJ-73763989 in Healthy Chinese Adult Participants
    Li, Haiyan
    Niu, Xiaoye
    Zhang, Yu
    Zhang, Danning
    Zhang, Yanqing
    Wang, Liqun
    Miao, Yongqing
    Jiang, Yanxin
    Ji, Jia
    Chen, Qiaoqiao
    Wu, Xiaoyun
    Ediage, Emmanuel Njumbe
    Kakuda, Thomas N.
    Biermer, Michael
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (02): : 175 - 180
  • [2] Plasma and Liver Pharmacokinetics of the N-Acetylgalactosamine Short Interfering RNA JNJ-73763989 in Recombinant Adeno-Associated-Hepatitis B Virus-Infected Mice
    Sandra, Louis
    T'Jollyn, Huybrecht
    Goeyvaerts, Nele
    Vermeulen, An
    Dosne, Anne-Gaeelle
    Perez-Ruixo, Juan -Jose
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2022, 383 (01): : 70 - 79
  • [3] FIRST CLINICAL EXPERIENCE WITH RNA INTERFERENCE [RNAi]-BASED TRIPLE COMBINATION THERAPY IN CHRONIC HEPATITIS B (CHB): JNJ-73763989 (JNJ-3989), JNJ-56136379 (JNJ-6379) AND A NUCLEOS(T)IDE ANALOGUE (NA)
    Yuen, Man-Fung
    Locarnini, Stephen
    Given, Bruce
    Schluep, Thomas
    Hamilton, James
    Biermer, Michael
    Kalmeijer, Ronald
    Beumont-Mauviel, Maria
    Lenz, Oliver
    Cloherty, Gavin
    Jackson, Kathy
    Ferrari, Carlo
    Lai, Ching Lung
    Liu, Kevin Sze-Hang
    Mak, Lung Yi
    Wong, Danny Ka Ho
    To, Wai Pan
    Ko, Kwan-Lung
    Gish, Robert G.
    HEPATOLOGY, 2019, 70 (06) : 1489A - 1489A
  • [4] JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B
    Gane, Ed
    Yuen, Man-Fung
    Kakuda, Thomas N.
    Ogawa, Tetsuro
    Takahashi, Yasushi
    Goeyvaerts, Nele
    Lonjon-Domanec, Isabelle
    Vaughan, Tamisha
    Schluep, Thomas
    Hamilton, James
    Njumbe Ediage, Emmanuel
    Hillewaert, Vera
    Snoeys, Jan
    Lenz, Oliver
    Talloen, Willem
    Biermer, Michael
    ANTIVIRAL THERAPY, 2022, 21 (01)
  • [5] Advantages of RNA interference in anti-hepatitis B virus therapy
    Zhang Xue-Zhi
    Shan Chang-Liang
    Ye Li-Hong
    Zhang Xiao-Dong
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2008, 35 (06) : 631 - 636
  • [6] Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects
    Vandenbossche, Joris
    Jessner, Wolfgang
    van den Boer, Maarten
    Biewenga, Jeike
    Berke, Jan Martin
    Talloen, Willem
    De Zwart, Loeckie
    Snoeys, Jan
    Yogaratnam, Jeysen
    ADVANCES IN THERAPY, 2019, 36 (09) : 2450 - 2462
  • [7] Development of Second Generation RNA Interference Therapy for Hepatitis B Virus Infection
    Thi, Emily P.
    Ye, Xin
    Dhillon, Ammen P.
    Snead, Nicholas M.
    Kondratowicz, Andrew S.
    Pei, Luying
    Cobarrubias, Kyle D.
    Jarosz, Agnes
    Wasney, Joseph
    Cuconati, Andrea
    Rijnbrand, Rene
    Lee, Amy C.
    Sofia, Michael J.
    HEPATOLOGY, 2016, 64 : 922A - 922A
  • [8] Progress in the use of RNA interference as a therapy for chronic hepatitis B virus infection
    Weinberg, Marc S.
    Arbuthnot, Patrick
    GENOME MEDICINE, 2010, 2
  • [9] Progress in the use of RNA interference as a therapy for chronic hepatitis B virus infection
    Marc S Weinberg
    Patrick Arbuthnot
    Genome Medicine, 2
  • [10] Pharmacokinetics, Safety and Tolerability of JNJ-56136379, a Novel Hepatitis B Virus Capsid Assembly Modulator, in Healthy Subjects
    Joris Vandenbossche
    Wolfgang Jessner
    Maarten van den Boer
    Jeike Biewenga
    Jan Martin Berke
    Willem Talloen
    Loeckie De Zwart
    Jan Snoeys
    Jeysen Yogaratnam
    Advances in Therapy, 2019, 36 : 2450 - 2462
123